Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis (MSNAC)
Sponsor: Thomas Jefferson University
This NA trial investigates Multiple Sclerosis and is currently ongoing. Thomas Jefferson University leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Oct 2025 — Present [monthly]
Enrolling By Invitation NA
-
Sep 2024 — Oct 2025 [monthly]
Enrolling By Invitation NA
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation NA
-
Apr 2024 — Jul 2024 [monthly]
Enrolling By Invitation NA
-
Sep 2022 — Apr 2024 [monthly]
Enrolling By Invitation NA
▶ Show 9 earlier versions
-
Jun 2022 — Sep 2022 [monthly]
Enrolling By Invitation NA
-
Jan 2022 — Jun 2022 [monthly]
Enrolling By Invitation NA
-
Dec 2021 — Jan 2022 [monthly]
Enrolling By Invitation NA
Status: Active Not Recruiting → Enrolling By Invitation
-
Jun 2021 — Dec 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
May 2019 — Aug 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Thomas Jefferson University
For direct contact, visit the study record on ClinicalTrials.gov .